跳至主要内容
临床试验/JPRN-UMIN000023961
JPRN-UMIN000023961已完成2 期

Carboplatin and TS-1 combination chemotherapy in cancer of unknown primary site : a phase II multicenter trial - CBDCA and TS-1 in CUP Phase II study

ational Cancer Center Hospital0 个研究点目标入组 35 人开始时间: 2016年9月6日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • a) favorable subset of CUP b) double cancer c) uncontrollable effusion in pleural or abdominal d) uncontrollable brain metastasis e)sever coexisting illness uncontrollable angina, AMI or congestive heart failure within 3 months, uncontrollable diabetes melitus active infection interstitial pneumonitis in CXR severe psychological problems uncontrollable diarrhea physician assessed the patient as ineligible the patients have to continue flucitocin, phenytoin and warfarin pregnant patients

研究者

相似试验